Akso Health Group (AHG)

$1.14

+0.04

(+3.64%)

Market is closed - opens 7 PM, 16 Jul 2024

Performance

  • $1.03
    $1.14
    $1.14
    downward going graph

    9.65%

    Downside

    Day's Volatility :9.8%

    Upside

    0.17%

    downward going graph
  • $0.25
    $2.90
    $1.14
    downward going graph

    78.03%

    Downside

    52 Weeks Volatility :91.36%

    Upside

    60.69%

    downward going graph

Returns

PeriodAkso Health GroupSector (Financials)Index (Russel 2000)
3 Months
35.8%
6.3%
0.0%
6 Months
-21.99%
12.7%
0.0%
1 Year
233.33%
23.7%
0.0%
3 Years
-45.54%
15.7%
-19.2%

Highlights

Market Capitalization
165.8M
Book Value
$0.23
Earnings Per Share (EPS)
-0.81
Profit Margin
-253.73%
Operating Margin TTM
-259.16%
Return On Assets TTM
-54.13%
Return On Equity TTM
-233.19%
Revenue TTM
2.2M
Revenue Per Share TTM
0.1
Quarterly Revenue Growth YOY
-92.5%
Gross Profit TTM
1.3M
EBITDA
-14.2M
Diluted Eps TTM
-0.81
Quarterly Earnings Growth YOY
0.0
EPS Estimate Current Year
0.0
EPS Estimate Next Year
0.0
EPS Estimate Current Quarter
0.0
EPS Estimate Next Quarter
0.0

Analyst Recommendation

Company Financials

FY18Y/Y Change
Revenue
107.3M
↑ 367.96%
Net Income
65.5M
↑ 664.01%
Net Profit Margin
61.05%
↑ 23.66%
FY19Y/Y Change
Revenue
61.3M
↓ 42.82%
Net Income
5.5M
↓ 91.55%
Net Profit Margin
9.02%
↓ 52.03%
FY20Y/Y Change
Revenue
11.4M
↓ 81.36%
Net Income
-71.2M
↓ 1386.89%
Net Profit Margin
-622.63%
↓ 631.65%
FY21Y/Y Change
Revenue
1.8M
↓ 84.65%
Net Income
-31.6M
↓ 55.68%
Net Profit Margin
-1.8K%
↓ 1175.29%
FY22Y/Y Change
Revenue
6.3M
↑ 259.62%
Net Income
-16.8M
↓ 46.6%
Net Profit Margin
-266.99%
↑ 1530.93%
FY23Y/Y Change
Revenue
6.3M
↑ 0.0%
Net Income
-16.8M
↑ 0.0%
Net Profit Margin
-266.99%
↑ 0.0%
Q2 FY22Q/Q Change
Revenue
5.9M
-
Net Income
815.4K
-
Net Profit Margin
13.75%
-
Q3 FY22Q/Q Change
Revenue
6.3T
↑ 1.0645237105E8%
Net Income
14.7M
↑ 1704.2%
Net Profit Margin
0.0%
↓ 13.75%
Q4 FY22Q/Q Change
Revenue
11.9M
↓ 100.0%
Net Income
810.3K
↓ 94.49%
Net Profit Margin
6.83%
↑ 6.83%
Q2 FY23Q/Q Change
Revenue
1.4M
↓ 88.61%
Net Income
-2.2M
↓ 372.63%
Net Profit Margin
-163.4%
↓ 170.23%
Q4 FY23Q/Q Change
Revenue
894.8K
↓ 33.82%
Net Income
-3.1M
↑ 38.88%
Net Profit Margin
-342.89%
↓ 179.49%
FY18Y/Y Change
Total Assets
163.9M
↑ 477.44%
Total Liabilities
23.8M
↑ 388.89%
FY19Y/Y Change
Total Assets
173.3M
↑ 5.71%
Total Liabilities
46.8M
↑ 96.05%
FY20Y/Y Change
Total Assets
78.4M
↓ 54.76%
Total Liabilities
30.3M
↓ 35.23%
FY21Y/Y Change
Total Assets
31.7M
↓ 59.58%
Total Liabilities
14.4M
↓ 52.4%
FY22Y/Y Change
Total Assets
50.7M
↑ 59.95%
Total Liabilities
38.4M
↑ 166.37%
FY23Y/Y Change
Total Assets
50.7M
↑ 0.0%
Total Liabilities
38.4M
↑ 0.0%
Q3 FY22Q/Q Change
Total Assets
50.7M
↑ 142.4%
Total Liabilities
38.4M
↑ 249.76%
Q4 FY22Q/Q Change
Total Assets
20.5M
↓ 59.63%
Total Liabilities
11.6M
↓ 69.73%
Q1 FY23Q/Q Change
Total Assets
20.5M
↑ 0.0%
Total Liabilities
11.6M
↑ 0.0%
Q2 FY23Q/Q Change
Total Assets
20.5M
↑ 0.0%
Total Liabilities
11.6M
↑ 0.0%
Q3 FY23Q/Q Change
Total Assets
16.9M
↓ 17.5%
Total Liabilities
11.5M
↓ 0.62%
Q4 FY23Q/Q Change
Total Assets
16.9M
↑ 0.0%
Total Liabilities
11.5M
↑ 0.0%
FY18Y/Y Change
Operating Cash Flow
87.7M
↑ 971.13%
Investing Cash Flow
-27.6M
-
Financing Cash Flow
47.5M
↑ 1007.95%
FY19Y/Y Change
Operating Cash Flow
-1.7M
↓ 101.97%
Investing Cash Flow
-68.1M
↑ 146.55%
Financing Cash Flow
-29.4K
↓ 100.06%
FY20Y/Y Change
Operating Cash Flow
-55.9M
↑ 3127.23%
Investing Cash Flow
12.8M
↓ 118.76%
Financing Cash Flow
-4.0M
↑ 13397.63%
FY21Y/Y Change
Operating Cash Flow
10.1M
↓ 118.0%
Investing Cash Flow
-662.0
↓ 100.01%
Financing Cash Flow
-9.0M
↑ 127.91%
FY22Y/Y Change
Operating Cash Flow
-8.6M
↓ 185.78%
Investing Cash Flow
-20.0M
↑ 3015588.82%
Financing Cash Flow
34.8M
↓ 484.87%
FY23Y/Y Change
Operating Cash Flow
-8.6M
↑ 0.0%
Investing Cash Flow
18.5M
↓ 192.52%
Financing Cash Flow
34.8M
↑ 0.0%
Q2 FY22Q/Q Change
Operating Cash Flow
-667.1K
↓ 100.89%
Investing Cash Flow
10.0M
-
Financing Cash Flow
-13.8M
↓ 129.28%
Q3 FY22Q/Q Change
Operating Cash Flow
-667.1K
↑ 0.0%
Investing Cash Flow
10.0M
↑ 0.0%
Financing Cash Flow
-13.8M
↑ 0.0%

Technicals Summary

Sell

Neutral

Buy

Akso Health Group is currently in a neutral trading position according to technical analysis indicators.

Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Akso Health Group
Akso Health Group
37.5%
-21.99%
233.33%
-45.54%
-45.54%
Cardinal Health, Inc.
Cardinal Health, Inc.
-6.79%
-11.54%
0.67%
65.76%
98.11%
Cencora Inc
Cencora Inc
-5.16%
1.64%
24.43%
61.49%
88.95%
Mckesson Corporation
Mckesson Corporation
-3.48%
18.05%
40.08%
204.31%
304.05%
Henry Schein, Inc.
Henry Schein, Inc.
-1.56%
-10.74%
-18.8%
-13.53%
-8.69%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Akso Health Group
Akso Health Group
NA
NA
NA
0.0
-2.33
-0.54
NA
0.23
Cardinal Health, Inc.
Cardinal Health, Inc.
42.3
42.3
0.31
7.36
0.0
0.03
0.02
-13.38
Cencora Inc
Cencora Inc
23.39
23.39
1.58
11.93
2.34
0.03
0.01
3.39
Mckesson Corporation
Mckesson Corporation
26.17
26.17
4.96
27.59
0.0
0.04
0.0
-15.16
Henry Schein, Inc.
Henry Schein, Inc.
21.61
21.61
1.65
5.07
0.08
0.04
NA
28.02
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Akso Health Group
Akso Health Group
NA
$165.8M
-45.54%
NA
-253.73%
Cardinal Health, Inc.
Cardinal Health, Inc.
Hold
$23.3B
98.11%
42.3
0.25%
Cencora Inc
Cencora Inc
Buy
$38.5B
88.95%
23.39
0.66%
Mckesson Corporation
Mckesson Corporation
Buy
$76.1B
304.05%
26.17
0.97%
Henry Schein, Inc.
Henry Schein, Inc.
Hold
$8.2B
-8.69%
21.61
3.12%

Insights on Akso Health Group

  • Decreasing Revenue

    Revenue is down for the last 4 quarters, 6311.07B → 894.76K (in $), with an average decrease of 74.1% per quarter

  • Decreasing Net Profit

    Netprofit is down for the last 4 quarters, 14.71M → -3.06M (in $), with an average decrease of 168.7% per quarter

Institutional Holdings

  • Renaissance Technologies Corp

    0.14%
  • Millennium Management LLC

    0.02%
  • Geode Capital Management, LLC

    0.01%
  • Rhumbline Advisers

    0.01%
  • XTX Topco Ltd

    0.01%

Company Information

和信电子商务有限公司 is a company based out of china.

Organization
Akso Health Group
Employees
12
CEO
Ms. Yilin Wang
Industry
Services

FAQs